JPWO2022197567A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022197567A5
JPWO2022197567A5 JP2023556985A JP2023556985A JPWO2022197567A5 JP WO2022197567 A5 JPWO2022197567 A5 JP WO2022197567A5 JP 2023556985 A JP2023556985 A JP 2023556985A JP 2023556985 A JP2023556985 A JP 2023556985A JP WO2022197567 A5 JPWO2022197567 A5 JP WO2022197567A5
Authority
JP
Japan
Prior art keywords
compound
isotope
metal
radioimaging
magnetic resonance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023556985A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510267A5 (https=
JP2024510267A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/020084 external-priority patent/WO2022197567A1/en
Publication of JP2024510267A publication Critical patent/JP2024510267A/ja
Publication of JP2024510267A5 publication Critical patent/JP2024510267A5/ja
Publication of JPWO2022197567A5 publication Critical patent/JPWO2022197567A5/ja
Pending legal-status Critical Current

Links

JP2023556985A 2021-03-16 2022-03-12 線維芽細胞活性化タンパク質を標的とする化合物、およびその使用方法 Pending JP2024510267A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US202163200592P 2021-03-16 2021-03-16
US202163161835P 2021-03-16 2021-03-16
US202163200593P 2021-03-16 2021-03-16
US63/161,835 2021-03-16
US63/200,593 2021-03-16
US63/200,592 2021-03-16
US202163165563P 2021-03-24 2021-03-24
US202163165583P 2021-03-24 2021-03-24
US202163165550P 2021-03-24 2021-03-24
US63/165,563 2021-03-24
US63/165,550 2021-03-24
US63/165,583 2021-03-24
PCT/US2022/020084 WO2022197567A1 (en) 2021-03-16 2022-03-12 Compounds targeting fibroblast-activation protein and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024510267A JP2024510267A (ja) 2024-03-06
JP2024510267A5 JP2024510267A5 (https=) 2025-03-21
JPWO2022197567A5 true JPWO2022197567A5 (https=) 2025-03-21

Family

ID=83320754

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023556985A Pending JP2024510267A (ja) 2021-03-16 2022-03-12 線維芽細胞活性化タンパク質を標的とする化合物、およびその使用方法

Country Status (6)

Country Link
US (1) US20240238458A1 (https=)
EP (1) EP4308110A4 (https=)
JP (1) JP2024510267A (https=)
CA (1) CA3212210A1 (https=)
TW (1) TW202300143A (https=)
WO (1) WO2022197567A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI879182B (zh) * 2023-10-26 2025-04-01 國家原子能科技研究院 白蛋白雙重結合功能之纖維母細胞活化蛋白化合物或其鹽
WO2025155818A1 (en) * 2024-01-19 2025-07-24 Purdue Research Foundation Fibroblast activation protein-targeted radioligands with pharmacokinetic modulators
WO2025171343A1 (en) * 2024-02-08 2025-08-14 Immunome, Inc. Compounds targeting fibroblast-activation protein and methods of use thereof
CN118593732B (zh) * 2024-06-27 2025-03-11 华中科技大学同济医学院附属同济医院 一种心肌炎核素分子探针及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1943257A2 (en) * 2005-05-19 2008-07-16 Genentech, Inc. Fibroblast activation protein inhibitor compounds and methods
US8071787B2 (en) * 2009-03-13 2011-12-06 National Health Research Institutes Pyrrolidine compounds
JP6744826B2 (ja) * 2014-06-13 2020-08-19 バック バイオサイエンシーズ, エルエルシーBach BioSciences, LLC Fap活性化治療剤及びそれに関連する使用
CN116474108A (zh) * 2016-12-14 2023-07-25 普渡研究基金会 成纤维细胞活化蛋白(fap)-靶向成像和治疗
JP7094591B2 (ja) * 2018-03-30 2022-07-04 フューチャーケム カンパニー リミテッド 前立腺がんを診断および処置するためのpsma標的放射性医薬品
US11426472B2 (en) * 2018-10-17 2022-08-30 Purdue Research Foundation Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis
EP3946320A4 (en) * 2019-04-03 2022-12-28 Tva (Abc), Llc CONJUGATES RELATED TO HSP90 AND FORMULATIONS THEREOF
WO2021016392A1 (en) * 2019-07-22 2021-01-28 Purdue Research Foundation Multivalent fibroblast-targeted agents and methods of use

Similar Documents

Publication Publication Date Title
JP7630149B2 (ja) Psmaを標的としたイメージング及び放射線治療のための金属/放射性金属標識psma阻害剤
JP7059372B2 (ja) デュアルモードの放射性トレーサーおよび療法剤
JP7449864B2 (ja) エバンスブルー誘導体の化学結合体ならびに前立腺癌を標的とするための放射線療法および造影剤としてのその使用
JP2833766B2 (ja) アミノポリカルボン酸およびその誘導体
Tu et al. PET imaging and biodistribution of silicon quantum dots in mice
CN109153641B (zh) 伊文思蓝衍生物的化学偶联物及其作为放射治疗和成像剂的用途
EP0755269B1 (en) Contrast agents
TW319763B (https=)
JP4056701B2 (ja) 薬剤および診断薬の送達のための高分子担体
CN1056162C (zh) 聚胺化的配位体及其金属配合物
JP2022518956A (ja) がん診断用画像化剤
JP2020518673A5 (https=)
RU2019139432A (ru) Фармакокинетическая оптимизация бифункциональных хелатов и их применение
JP3020938B2 (ja) 大環状の置換ポリアミノカルボン酸の金属キレ―トと診断用イメ―ジングにおけるその使用
Anelli et al. Conjugates of gadolinium complexes to bile acids as hepatocyte-directed contrast agents for magnetic resonance imaging
Shi et al. Multifunctional transferrin encapsulated GdF3 nanoparticles for sentinel lymph node and tumor imaging
JPH02196761A (ja) オルト結合官能性を有するキレート剤類およびそれらの錯塩類
AU2016416524A1 (en) Radioactive phospholipid metal chelates for cancer imaging and therapy
JPWO2022197567A5 (https=)
JPH06502177A (ja) 磁気共鳴映像用ポリマー−デフェロキサミン−第2鉄付加物
JPH07500574A (ja) ポリアミンのヒドロキサメートならびにヒドラジド誘導体、およびキレート化剤としてのこれらの医療用途
Yao et al. Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer
CN112601740B (zh) 用于治疗黑素瘤的放射性化合物及其用途
JPWO2021055641A5 (https=)
WO2025059025A1 (en) Zwitterionic metal chelators